Continuous blood pressure monitoring in cirrhosis: Relations to splanchnic and systemic haemodynamics

Journal of Hepatology

Volumn 27, Issue 2, 1997, Pages 284-294

  Møller, Søren ^a   Christensen, Erik ^a   Henriksen, Jens H ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Ambulatory blood pressure monitoring; Central blood volume; Central circulation time; Cirrhosis; Haemodynamics; Hyperdynamic circulation; Portal hypertension

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; HYPOTENSION; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; SODIUM RETENTION; SPLANCHNIC BLOOD FLOW; WATER RETENTION;

EID: 0030798965     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80173-0     Document Type: Article

References (47)

1. Henriksen JH. Systemic haemodynamic alterations in hepatic cirrhosis. Eur J Gastroenterol Hepatol. 3:1991;705-713.
2. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral artery vasodilatation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 5:1988;1151-1157.
3. Sherlock S. Vasodilatation associated with hepatocellular disease: relation to functional organ failure. Gut. 31:1990;365-367.
4. Henriksen JH, Bendtsen F, Sørensen TIA, Stadeager C, Ring - Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology. 97:1989;1506-1513.
5. Henriksen JH, Bendtsen F, Gerbes AL, Christensen NJ, Ring-Larsen H, Sørensen TIA. Estimated central blood volume in cirrhosis. Relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor. Hepatology. 16:1992;1163-1170.
6. Schrier RW, Niederberger M, Weigert A, Gines P. Peripheral arterial vasodilatation: Determination of functional spectrum of cirrhosis. Semin Liver Dis. 14:1994;14-22.
7. Møller S, Wiinberg N, Henriksen JH. Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology. 22:1995;88-95.
8. Llach J, Ginés P, Arroyo V, Rimola A, Titó L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology. 94:1988;482-487.
9. Friedman HS, Fernando H. Ascites as a marker for the hyperdynamic heart of Laennec's cirrhosis. Alcohol Clin Exp Res. 16:1992;968-970.
10. Sherlock S, Dooley J. 9th ed Diseases of the Liver and Biliary System. 1993;Blackwell, Oxford.
11. The Copenhagen Study Group for Liver Diseases Gluud C. Serum testosterone concentration in men with alcoholic cirrhosis: Background for variation. Metabolism. 36:1987;373-378.
12. Høegholm A, Eidemark I, Kristensen KS, Bang LE, Madsen NH. Clinical evaluation of the Takeda Medical (A & D) TM 2420 ambulatory blood pressure monitor. Practical experience and comparison with direct and indirect measurements. Scand J Clin Lab Invest. 52:1992;261-268.
13. Jamieson MJ, Fowler G, MacDonald TM, Webster J, Witte K, Lawson L, et al. Bench and ambulatory field evaluation of the A & D TM-2420 automated sphygmomanometer. J Hypertension. 8:1990;599-605.
14. Clark S, Fowlie S, Coats A, Radaelli A, Putt Mvd, Bird R, et al. Ambulatory blood pressure monitoring: validation of the accuracy and reliability of the TM-2420 according to AAMI recommendations. J Human Hypertension. 5:1991;77-82.
15. White WB, Pickering TG, Morganroth J, James GD, McCabe EJ, Moucha O, et al. A multicenter evaluation of the A & D TM-2420 ambulatory blood pressure recorder. Am J Hypertens. 4:1991;890-896.
16. Henriksen JH, Ring-Larsen H, Kanstrup I-L, Christensen NJ. Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with cirrhosis. Gut. 25:1984;1034-1043.
17. Henriksen JH, Winkler W. Hepatic blood flow determination. A comparison of 99-Tc-diethyl-IDA and indocyanine green as hepatic blood flow indicators in man. J Hepatol. 4:1987;66-70.
18. Tygstrup N. Determination of the hepatic galactose elimination capacity after a single intravenous injection in man. Acta Physiol Scand. 58:1963;162-172.
19. Henriksen JH, Ring-Larsen H, Christensen NJ. Circulating noradrenaline and central haemodynamics in patients with cirrhosis. Scand J Gastroenterol. 20:1985;1185-1190.
20. Lassen NA, Perl W. Tracer Kinetics Methods in Medical Physiology. 1979;Raven, New York.
21. Armitage P, Berry G. 2nd ed Statistical Methods in Medical Research. 1990;Blackwell, Oxford.
22. Wiinberg N, Walther-Larsen S, Eriksen C, Nielsen PE. An evaluation of semi-automatic blood pressure manometers against intra-arterial blood pressure. J Amb Monit. 1:1988;303-309.
23. Stanek B, Renner A, Sedlmayer A, Silberbauer K. Effect of captopril on renin and blood pressure in cirrhosis. Eur J Clin Pharmacol. 33:1987;249-254.
24. Arroyo V, Gines P. Mechanism of sodium retention and ascites formation in cirrhosis. J Hepatol. 17:1993;S24-S28.
25. Bernardi M, Trevisani F, Gasbarrini A, Gasbarrini G. Hepatorenal disorders. Role of the renin-angiotensin-aldosterone system. Semin Liver Dis. 14:1994;23-34.
26. Simon MA, Diez J, Prieto J. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis. Gastroenterology. 101:1991;1354-1360.
27. Moreau R, Gaudin C, Hadengue A, Braillon A, Roulot D, Bacq Y, et al. Renal hemodynamics in patients with cirrhosis. Relationship with ascites and liver failure. Nephron. 65:1993;359-363.
28. Epstein M. Hepatorenal syndrome - Emerging perspectives of pathophysiology and therapy. J Am Soc Nephrol. 4:1994;1735-1753.
29. Maroto A, Gines P, Arroyo V, Gines A, Salo J, Claria J, et al. Brachial and femoral artery blood flow in cirrhosis. Relationship to kidney dysfunction. Hepatology. 17:1993;788-793.
30. Cereda J-M, Roulot D, Braillon A, Moreau R, Koshy A, Lebrec D. Reduction of portal pressure by acute administration of furosemide in patients with alcoholic cirrhosis. J Hepatol. 9:1989;246-251.
31. Okumura H, Aramaki T, Katsuta Y, Satomura K, Akaike M, Sekiyama T, et al. Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spirololactone in patients with cirrhosis and no ascites. Am J Gastroenterol. 86:1991;46-52.
32. Nevens F, Lijnen P, Vanbilloen H, Fevery J. The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites. Hepatology. 23:1996;1047-1052.
33. Li MKK, Sung JJY, Woo KS, Anderson J, Leung NWY, Yu LM, et al. Somatostatin reduces gastric mucosal blood flow in patients with portal hypertensive gastropathy: A randomized, double-blind crossover study. Dig Dis Sci. 41:1996;2440-2446.
34. Ring-Larsen H, Palazzo U. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types and prognosis. Gut. 22:1981;585-591.
35. Caregaro L, Alberino F, Amodio P, Merkel C, Bolognesi M, Angeli P, et al. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr. 63:1996;602-609.
36. Lafleur M, Labelle F, Lemoyne M, Gelinas MD. Nutritional assessment in chronic liver disease patients: A comparison between skeletal muscle function and standard nutritional parameters. Nutr Res. 16:1996;545-553.
37. Groszmann RJ. Vasodilatation and hyperdynamic circulatory state in chronic liver disease. Bosch J, Groszmann RJ. Portal Hypertension. Pathophysiology and Treatment. 1994;70-89 Blackwell, Oxford.
38. Orrego H, Carmichael FJ. Effect of alcohol on liver haemodynamics in the presence and absence of liver disease. J Gastroenterol Hepatol. 7:1992;70-89.
39. García-Pagán JC, Feu F, Castells A, Hermida RC, Luca A, Rivera F, et al. Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis. Hepatology. 19:1994;595-601.
40. Alvarez D, Golombek D, Lopez P, Heras MD, Viola L, Sanchez S, et al. Diurnal fluctuations of portal and systemic hemodynamic parameters in patients with cirrhosis. Hepatology. 20:1994;1198-1203.
41. Hartleb M, Rudzki K. Segmental mean transit times of technetium-99m within central vascular space in liver cirrhosis. Liver. 12:1992;191-198.
42. Møller S, Bendtsen F, Christensen E, Henriksen JH. Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding. J Hepatol. 21:1994;940-946.
43. Møller S, Søndergaard L, Møgelvang J, Henriksen O, Henriksen JH. Decreased right heart blood volume determined by magnetic resonance imaging: Evidence of central underfilling in cirrhosis. Hepatology. 22:1995;472-478.
44. Lassen NA, Henriksen O, Sejrsen P. Indicator methods for measurement of organ and tissue blood flow. Handbook of Physiology: The Cardiovascular System III. 1984;21-63 Muksgaard, Copenhagen.
45. Schrier RW, RL Howard. Unifying hypothesis of sodium and water regulation in health and disease. Hypertension. 18:1991;164-168. (Suppl III).
46. Hadengue A, Moreau R, Gaudin C, Bacq Y, Champigneulle B, Lebrec D. Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion. Hepatology. 15:1992;809-815.
47. Arroyo V, Gines P, Planas R. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis. Gastroenterol Clin North Am. 21:1992;237-256.